Profound Medical (PROF) Gains from Investment Securities (2018 - 2026)
Profound Medical's quarterly Gains from Investment Securities came in at $25000.0 in Q1 2026, up 247.22% year-on-year from $7200.0 in Q1 2025, and down 98.83% quarter-over-quarter from $2.1 million in Q4 2025.
Profound Medical has reported Gains from Investment Securities for 8 years, with the latest figure at $25000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 247.22% year-over-year to $25000.0; the trailing twelve-month figure through Mar 2026 stood at $237000.0 (up 3191.67% YoY), and the FY2025 full-year result was $2.1 million, down 6.49% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $25000.0, down from $2.1 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.3 million in Q4 2024, with the low at $7200.0 in Q1 2025.
- Average Gains from Investment Securities over 5 years is $723011.7, with a median of $160000.0 recorded in 2024.
- Peak annual rise in Gains from Investment Securities reached 517.3% in 2025, while the deepest fall reached 66.19% in 2025.
- Tracing PROF's Gains from Investment Securities over 5 years: stood at $1.5 million in 2022, then fell by 2.45% to $1.5 million in 2023, then jumped by 55.35% to $2.3 million in 2024, then dropped by 6.49% to $2.1 million in 2025, then sank by 98.83% to $25000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $25000.0 (Q1 2026), $2.1 million (Q4 2025), and $234573.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 234,573.00 |
| Sep 30, 2025 | 234,573.00 |
| Jun 30, 2025 | 54,100.00 |
| Jun 30, 2025 | 54,100.00 |
| Mar 31, 2025 | 7,200.00 |
| Mar 31, 2025 | 7,200.00 |
| Dec 31, 2024 | 2.29 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Dec 31, 2020 | 90,000.00 |
| Dec 31, 2020 | 90,000.00 |
| Sep 30, 2020 | 30,116.00 |
| Sep 30, 2020 | 30,116.00 |
| Jun 30, 2020 | -2,195.34 |
| Jun 30, 2020 | -2,195.34 |
| Mar 31, 2020 | 11,000.00 |
| Mar 31, 2020 | 11,000.00 |
| Dec 31, 2019 | -623,000.00 |
| Dec 31, 2019 | -623,000.00 |
| Sep 30, 2019 | -123,228.26 |
| Sep 30, 2019 | -123,228.26 |
| Jun 30, 2019 | -101,672.75 |
| Jun 30, 2019 | -101,672.75 |
| Mar 31, 2019 | -54,798.33 |
| Mar 31, 2019 | -54,798.33 |
| Dec 31, 2018 | -154,247.60 |
| Dec 31, 2018 | -154,247.60 |